CD4 and COVID-19: Similarly, the α-CCCs/SARS-CoV-2 cross-reactive epitopes were strongly cross-recognized by IFN-γ+CD4+ T cells (SFCs>50) and CD8+ T cells from both unexposed pre-pandemic healthy individuals (UPPHI) and unvaccinated asymptomatic COVID-19 patients.